Article

Fourth-generation fluoroquinolones offer improved coverage

Fort Lauderdale, FL-The investigational fourth-generation fluoroquinolones moxifloxacin and gatifloxacin show prom-ising potential for providing broad- spectrum coverage against important gram-negative and gram-positive ocular pathogens, according to results of in vitro susceptibility testing presented at the annual meeting of the Association for Research in Vision and Ophthalmology.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) CCOI sets the stage for global ophthalmic innovation at Stanford Summit on July 23
(Image credit: Ophthalmology Times) Accelerating eye health innovation through CCOI – Stanford Summit
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
© 2025 MJH Life Sciences

All rights reserved.